Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure

Eur J Heart Fail. 2020 May;22(5):903-906. doi: 10.1002/ejhf.1801. Epub 2020 Apr 3.

Authors

Haye H van der Wal¹, Niels Grote Beverborg^{1

2}, Jozine M Ter Maaten¹, Joanna S J Vinke³, Martin H de Borst³, Dirk J van Veldhuisen¹, Adriaan A Voors¹, Peter van der Meer¹

Affiliations

¹ Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
² Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
³ Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Anemia, Iron-Deficiency* / complications
Anemia, Iron-Deficiency* / epidemiology
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Female
Fibroblast Growth Factor-23
Fibroblast Growth Factors
Heart Failure* / epidemiology
Humans
Iron
Middle Aged
Stroke Volume
Ventricular Function, Left

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Fibroblast Growth Factors
Fibroblast Growth Factor-23
Iron